Impact of the new membrane-targeting lipoglycopeptide antibiotic MCC5145 on the treatment of bacteremic pneumococcal pneumonia in mice.

Ogunniyi, Abiodun D; Nguyen, Hang Thi; Hansford, Karl A; Cooper, Matthew A; Trott, Darren J; Blaskovich, Mark A T

Ogunniyi, Abiodun D; Nguyen, Hang Thi; Hansford, Karl A; Cooper, Matthew A; Trott, Darren J; Blaskovich, Mark A T.

Afiliación

Ogunniyi AD; Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide , Roseworthy, South Australia, Australia.
Nguyen HT; Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide , Roseworthy, South Australia, Australia.
Hansford KA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland , Brisbane, Queensland, Australia.
Cooper MA; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland , Brisbane, Queensland, Australia.
Trott DJ; Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide , Roseworthy, South Australia, Australia.
Blaskovich MAT; Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland , Brisbane, Queensland, Australia.

Microbiol Spectr ; : e0445922, 2023 Aug 22.

Article en En | MEDLINE | ID: mdl-37606382

Palabras clave

Streptococcus pneumoniae; antimicrobial agents; bacteremic pneumococcal pneumonia; bioluminescence; immunocompromised hosts; lipoglycopeptide; pneumococcus; pneumonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Tipo de estudio: Prognostic_studies Idioma: En Revista: Microbiol Spectr Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google